Administration of Radioactive Substances Advisory Committee (ARSAC) Triennial Review - Call for Evidence

Closed 5 Dec 2014

Opened 14 Nov 2014

Overview

In recent years, the health and social care system in England has undergone substantial change. The Health and Social Care Act 2012 and the Care Act 2014 have devolved functions and powers away from the Department of Health to local and Arm’s Length Bodies.

In this new system, the Department has a stewardship and assurance function designed to ensure that the new system and the multiple new and reformed bodies within it have the appropriate functions and are performing to a high standard.

To perform this stewardship function, the Department is putting in place Triennial Reviews of all its Arm’s Length Bodies. This includes all Executive Non-Departmental Public Bodies (ENDPBs), Advisory Non-Departmental Bodies (ANDPBs), Executive Agencies (EA) and Special Health Authorities (SpHA). As an ANDPB, the Administration of Radioactive Substances Advisory Committee is subject to review in 2014-15.

The programme of reviews builds on the approach developed by the Cabinet Office as part of their work on Public Bodies Reform.

This review is part of a wider programme the Department of Health has developed in support of its stewardship and assurance function. The review has two main aims which will be undertaken simultaneously:

  • The first is to provide a robust challenge to the continuing need for the Administration of Radioactive Substances Advisory Committee, both in terms of the functions it performs and the model and approach in which these are delivered.
  • The second will be consideration of the Administration of Radioactive Substances Advisory Committee’s governance, performance and capability as well as exploring opportunities for efficiencies.

Why We Are Consulting

In order to conduct the review in an open and transparent manner and ensure that the findings are rigorous and evidence-based, the review team is seeking the views of a wide range of stakeholders. We are interested in the views of individuals and organisations that engage with the Administration of Radioactive Substances Advisory Committee or have a wider interest in its operations.

Interested stakeholders are also invited to attend a workshop to share their views on this Call for Evidence.

25 November 2014               11:00-13:00 hours            London

https://www.eventbrite.co.uk/e/arsac-triennial-review-workshop-tickets-14189121043

Confidentiality

Information provided in response to this consultation, including personal information, may be published or disclosed in accordance with the access to information regimes (these are primarily the Freedom of Information Act 2000 (FOIA) and the Data Protection Act 1998 (DPA).

If you want the information that you provide to be treated as confidential, please be aware that under the FOIA, there is a statutory Code of Practice with which public authorities must comply and which deals, amongst other things, with obligations of confidence. In view of this, it would be helpful if you could explain to us why you regard the information you have provided as confidential. If we receive a request for disclosure of the information, we will take full account of your explanation, but we cannot give an assurance that confidentiality can be maintained in all circumstances. An automatic confidentiality disclaimer generated by your IT system will not, of itself, be regarded as binding on the Department of Health and a Ministry of State.

The Department will process your personal data in accordance with the DPA and in the majority of circumstances this will mean that your personal data will not be disclosed to third parties.

 

What Happens Next

The Triennial Review of the Administration of Radioactive Substances Advisory Committee (ARSAC) has commenced and will be completed by the end of December 2014. The conclusions of the review will be announced in both Houses of Parliament and a copy of the final report will be published on the Department of Health website in early 2015.

Audiences

  • Civil society
  • Clinicians
  • Managers
  • Commissioners
  • Pharmacists
  • Doctors
  • Healthcare scientists
  • Dentists
  • Diagnostic radiographers
  • Therapeutic radiographers
  • Allied Health Professionals
  • Foundation Trusts
  • Clinical Commissioning Groups
  • Regulatory body
  • Academic/ Professional institution
  • Employer representatives
  • Employee representatives
  • Royal Colleges

Interests

  • Children's health and development
  • Physical health
  • Environment
  • Health protection
  • Primary care
  • Training
  • Commissioning
  • Clinical Governance
  • Regulation